Administrative management of Mount Sinai PD consortium
西奈山PD财团的行政管理
基本信息
- 批准号:10284433
- 负责人:
- 金额:$ 3.11万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-09-15 至 2023-08-31
- 项目状态:已结题
- 来源:
- 关键词:AdministratorAnimal ExperimentationBiological AssayClinical DataClinical ResearchCollaborationsCommunicationCommunitiesCongressesDataData AnalysesData CollectionData Storage and RetrievalDecision MakingDevelopmentEnsureEvaluationFoundationsFutureGeneticGoalsGrantGuidelinesHealth systemHospitalsInstitutesInstitutionIntramural ResearchIsraelMaintenanceMolecularNational Institute of Neurological Disorders and StrokeNeurologyNeurosciencesOffice of Administrative ManagementOperations ResearchOutcomes ResearchParkinson DiseaseParticipantPathogenesisPoliciesPreparationProcessRegulationResearchResearch ActivityResearch PersonnelResearch Project GrantsSoftware ToolsStandardizationTimeTimeLineUnited States National Institutes of HealthVertebratesbasebiobankcohortconflict resolutiondata sharingfeasibility researchfollow-upgenome sciencesgut-brain axishuman subjectmedical schoolsmemberoperationrecruitsuccess
项目摘要
Summary (Admin Core)
The primary goal of the P20 Administrative Core (Admin Core) is to provide the central support to all activities of
the research, administration, finance, and communications among the three feasibility research projects and
collaboration with other intramural research departments and institutes. The Admin Core will integrate
administrative management for the investigators in the P20 that are based in The Mount Sinai Hospital (main
campus) and Mount Sinai-Beth Israel (downtown). It serves as a hub for communication with PD clinical and
research community at Mount Sinai Health system. Furthermore, the Admin Core aims to establish
organizational basis for a future NINDS Udall Center application. The specific aims include 1. Planning and
management of research activities; 2. Compliance administration of the Center operations and data sharing; 3.
Management of human subject recruitment and data sharing; 4. Coordination of efforts and timelines in the
preparation of Udall Center application.
摘要(管理核心)
P20管理核心(Admin Core)的主要目标是为P20的所有活动提供中央支持。
三个可行性研究项目之间的研究、行政、财务和沟通,
与其他校内研究部门和研究所合作。管理核心将整合
西奈山医院(主要)P20研究者的行政管理
校园)和西奈山-贝斯以色列(市中心)。它作为与PD临床和
西奈山卫生系统的研究社区。此外,管理核心旨在建立
这是未来NINDS Udall中心应用程序的组织基础。具体目标包括1.规划和
研究活动管理; 2.中心运营和数据共享的合规管理; 3.
管理人类受试者招募和数据共享; 4.协调联合国系统的努力和时间表
Udall中心申请的准备工作。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Zhenyu Yue其他文献
Zhenyu Yue的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Zhenyu Yue', 18)}}的其他基金
Deciphering LRRK2 pathophysiology in mediating gut-brain axis of PD using novel genetic mouse models
使用新型遗传小鼠模型解读 LRRK2 介导 PD 肠脑轴的病理生理学
- 批准号:
10284434 - 财政年份:2021
- 资助金额:
$ 3.11万 - 项目类别:
Determining the neuroprotective mechanism for microglial autophagy in Alzheimer's disease
确定阿尔茨海默病中小胶质细胞自噬的神经保护机制
- 批准号:
10581646 - 财政年份:2021
- 资助金额:
$ 3.11万 - 项目类别:
Determining the neuroprotective mechanism for microglial autophagy in Alzheimer's disease
确定阿尔茨海默病中小胶质细胞自噬的神经保护机制
- 批准号:
10430042 - 财政年份:2021
- 资助金额:
$ 3.11万 - 项目类别:
Determining the neuroprotective mechanism for microglial autophagy in Alzheimer's disease
确定阿尔茨海默病中小胶质细胞自噬的神经保护机制
- 批准号:
10213290 - 财政年份:2021
- 资助金额:
$ 3.11万 - 项目类别:
Determining Selective Autophagy Kinase in Modulating Neurotoxicity in Huntington's Disease Model
确定选择性自噬激酶在亨廷顿病模型中调节神经毒性的作用
- 批准号:
10656193 - 财政年份:2020
- 资助金额:
$ 3.11万 - 项目类别:
Determining selective autophagy kinase in modulating neurotoxicity in Huntington's disease model
确定选择性自噬激酶在亨廷顿病模型中调节神经毒性的作用
- 批准号:
10033925 - 财政年份:2020
- 资助金额:
$ 3.11万 - 项目类别:
Determining selective autophagy kinase in modulating neurotoxicity in Huntington's disease model
确定选择性自噬激酶在亨廷顿病模型中调节神经毒性的作用
- 批准号:
10438575 - 财政年份:2020
- 资助金额:
$ 3.11万 - 项目类别:
Determining selective autophagy kinase in modulating neurotoxicity in Huntington's disease model
确定选择性自噬激酶在亨廷顿病模型中调节神经毒性的作用
- 批准号:
10213157 - 财政年份:2020
- 资助金额:
$ 3.11万 - 项目类别:
DISTINCT REGULATION OF AUTOPHAGIC ACTIVITY BY TWO NOVEL PROTEINS
两种新型蛋白质对自噬活性的独特调节
- 批准号:
8361544 - 财政年份:2011
- 资助金额:
$ 3.11万 - 项目类别:
DISTINCT REGULATION OF AUTOPHAGIC ACTIVITY BY TWO NOVEL PROTEINS
两种新型蛋白质对自噬活性的独特调节
- 批准号:
8169173 - 财政年份:2010
- 资助金额:
$ 3.11万 - 项目类别:
相似海外基金
Development of a Drosophila-based platform to replace and reduce animal experimentation in epilepsy research
开发基于果蝇的平台来取代和减少癫痫研究中的动物实验
- 批准号:
NC/V001051/1 - 财政年份:2020
- 资助金额:
$ 3.11万 - 项目类别:
Research Grant
Doctoral Dissertation Research: Ethical Issues in Animal Experimentation
博士论文研究:动物实验的伦理问题
- 批准号:
1424484 - 财政年份:2014
- 资助金额:
$ 3.11万 - 项目类别:
Standard Grant
Tissue formation involving stem/progenitor cell research and animal experimentation (N01)
涉及干/祖细胞研究和动物实验的组织形成(N01)
- 批准号:
30245585 - 财政年份:2006
- 资助金额:
$ 3.11万 - 项目类别:
Collaborative Research Centres
Animal Experimentation system as an infrastructure to support translational progression of diabetes research to medical practice
动物实验系统作为支持糖尿病研究向医学实践转化的基础设施
- 批准号:
17200029 - 财政年份:2005
- 资助金额:
$ 3.11万 - 项目类别:
Grant-in-Aid for Scientific Research (A)
Animal experimentation and cardiac phenotyping of transgenic mouse models
转基因小鼠模型的动物实验和心脏表型分析
- 批准号:
13327687 - 财政年份:2005
- 资助金额:
$ 3.11万 - 项目类别:
Research Units














{{item.name}}会员




